• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Eli Lilly

Eli Lilly

Principal Large Cap Growth R3 PLGPX 2 Star

Last Price$8.95Day Change (%)0.45%
Open Price$8.95Day Change ($)0.04
Day Range8.95–8.9552-Week Range8.66–10.44

As of Mon 01/16/2017 | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Diabetes Market: Industry Analysis & Outlook 2016-2020 Featuring Sanofi, Takeda, Eli Lilly & Novo Nordisk - Research and Markets

    Global Diabetes Market: Industry Analysis & Outlook 2016-2020 Featuring Sanofi, Takeda, Eli Lilly & Novo Nordisk - Research and Markets

  2. Chi-Med Initiates a Phase II Combination Study of Fruquintinib with Iressa® (gefitinib) in First-Line Non-Small Cell Lung Cancer

    Chi-Med Initiates a Phase II Combination Study of Fruquintinib with Iressa® (gefitinib) in First-Line Non-Small Cell Lung Cancer

  3. Chi-Med Presents Phase I/II Clinical Data for Selective VEGFR Inhibitor Fruquintinib at the 2017 Gastrointestinal Cancers Symposium

    Chi-Med Presents Phase I/II Clinical Data for Selective VEGFR Inhibitor Fruquintinib at the 2017 Gastrointestinal Cancers Symposium

  4. UPDATE: Stocks pare losses following worst Dow, S&P 500 daily drop since October

    UPDATE: Stocks pare losses following worst Dow, S&P 500 daily drop since October

  5. MARKET SNAPSHOT: Stocks Pare Losses Following Worst Dow, S&P 500 Daily Drop Since October

    MARKET SNAPSHOT: Stocks Pare Losses Following Worst Dow, S&P 500 Daily Drop Since October

  6. Libya Western Libya Gas Project (Wafa and Bahr Essalam) Project Panorama Oil and Gas Upstream Analysis Report - Research and Markets

    Libya Western Libya Gas Project (Wafa and Bahr Essalam) Project Panorama Oil and Gas Upstream Analysis Report - Research and Markets

  7. UPDATE: Five unpopular, but prudent, things for investors to do near Dow 20,000

    UPDATE: Five unpopular, but prudent, things for investors to do near Dow 20,000

  8. Five unpopular, but prudent, things for investors to do near Dow 20,000

    Five unpopular, but prudent, things for investors to do near Dow 20,000

  9. UPDATE: In the age of Uber and Lyft, it's still hard for some Americans to get to the doctor

    UPDATE: In the age of Uber and Lyft, it's still hard for some Americans to get to the doctor

  10. UPDATE: In the age of Uber and Lyft, it's -2-

    UPDATE: In the age of Uber and Lyft, it's -2-

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.